Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyu Bi

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Scientific Reports|August 9, 2025
Efficacy and safety of anlotinib monotherapy for advanced hepatocellular carcinoma and clinical role of α-fetoproteinJianping Chang, Bowen Xu, Zhiyu Li, et al.
Cancer Cell International|April 6, 2024
MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1Zhicheng Wei, Bowen Xu, Yanjiang Yin, et al.
Computational and Structural Biotechnology Journal|January 12, 2024
Machine learning for metabolic pathway optimization: A reviewYang Cheng, Xinyu Bi, Yameng Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 17, 2024
A Multi-Omics, Machine Learning-Aware, Genome-Wide Metabolic Model of Bacillus Subtilis Refines the Gene Expression and Cell Growth PredictionXinyu Bi, Yang Cheng, Xueqin Lv, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2024
Nuclear p62 condensates stabilize the promyelocytic leukemia nuclear bodies by sequestering their ubiquitin ligase RNF4Afu Fu, Zhiwen Luo, Tamar Ziv, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 19, 2014
[A clinicopathological and prognostic study of rare pathological subtype cases of hepatocellular carcinoma]Zhiyu Li, Xinyu Bi, Lin Yang, et al.
Oncotarget|April 22, 2017
Should surgery be conducted for small nonfunctioning pancreatic neuroendocrine tumors: a systemic reviewJingfei Guo, Jianjun Zhao, Xinyu Bi, et al.
Bioresource Technology|December 12, 2022
Artificial intelligence technologies in bioprocess: Opportunities and challengesYang Cheng, Xinyu Bi, Yameng Xu, et al.
Current Opinion in Biotechnology|April 30, 2022
New synthetic biology tools for metabolic controlXueqin Lv, Angeles Hueso-Gil, Xinyu Bi, et al.
Zhonghua Yi Xue Za Zhi|December 17, 2014
[Correlation of alpha fetoprotein with the prognosis of hepatocellular carcinoma after hepatectomy in an ethnic Chinese population]Xinyu Bi, Tao Yan, Hong Zhao, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Scientific Reports|August 9, 2025
Efficacy and safety of anlotinib monotherapy for advanced hepatocellular carcinoma and clinical role of α-fetoproteinJianping Chang, Bowen Xu, Zhiyu Li, et al.
Cancer Cell International|April 6, 2024
MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1Zhicheng Wei, Bowen Xu, Yanjiang Yin, et al.
Computational and Structural Biotechnology Journal|January 12, 2024
Machine learning for metabolic pathway optimization: A reviewYang Cheng, Xinyu Bi, Yameng Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 17, 2024
A Multi-Omics, Machine Learning-Aware, Genome-Wide Metabolic Model of Bacillus Subtilis Refines the Gene Expression and Cell Growth PredictionXinyu Bi, Yang Cheng, Xueqin Lv, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2024
Nuclear p62 condensates stabilize the promyelocytic leukemia nuclear bodies by sequestering their ubiquitin ligase RNF4Afu Fu, Zhiwen Luo, Tamar Ziv, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 19, 2014
[A clinicopathological and prognostic study of rare pathological subtype cases of hepatocellular carcinoma]Zhiyu Li, Xinyu Bi, Lin Yang, et al.
Oncotarget|April 22, 2017
Should surgery be conducted for small nonfunctioning pancreatic neuroendocrine tumors: a systemic reviewJingfei Guo, Jianjun Zhao, Xinyu Bi, et al.
Bioresource Technology|December 12, 2022
Artificial intelligence technologies in bioprocess: Opportunities and challengesYang Cheng, Xinyu Bi, Yameng Xu, et al.
Current Opinion in Biotechnology|April 30, 2022
New synthetic biology tools for metabolic controlXueqin Lv, Angeles Hueso-Gil, Xinyu Bi, et al.
Zhonghua Yi Xue Za Zhi|December 17, 2014
[Correlation of alpha fetoprotein with the prognosis of hepatocellular carcinoma after hepatectomy in an ethnic Chinese population]Xinyu Bi, Tao Yan, Hong Zhao, et al.
Pageof 14